Indianapolis, IN, United States of America

P Douglas Walling

This inventor holds 9 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Roche Diabetes Care, Inc., Boehringer Mannheim Gmbh, Roche Diagnostics Operations, Inc.. Active years: 1996-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: P Douglas Walling. Retrieved from https://idiyas.com/inventor/p-douglas-walling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9

 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 623(Granted Patents)


Company Filing History:


Years Active: 1996-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Inventor Profile of P Douglas Walling

Introduction: P Douglas Walling is a distinguished inventor based in Indianapolis, Indiana, known for his groundbreaking contributions to various fields.

Latest Patents: P Douglas Walling holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, P Douglas Walling has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have made a significant impact.

Collaborations: Throughout his career, P Douglas Walling has collaborated with leading companies, research institutions, and universities to bring his inventions to life, highlighting his ability to work across disciplines and industries.

Conclusion: P Douglas Walling's passion for innovation and his dedication to creating solutions that improve lives make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…